BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND CCDC6, D10S170, 8030, ENSG00000108091, Q16204, TPC, H4, TST1
267 results:

  • 1. Discovery of novel benzimidazole derivatives as potent HDACs inhibitors against leukemia with (Thio)Hydantoin as zinc-binding moiety: Design, synthesis, enzyme inhibition, and cellular mechanistic study.
    Abdulwahab HG; Mansour RE; Farghaly TA; El-Sehrawi HM
    Bioorg Chem; 2024 May; 146():107284. PubMed ID: 38493640
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Extending MeCP2 interactome: canonical nucleosomal histones interact with MeCP2.
    Ortega-Alarcon D; Claveria-Gimeno R; Vega S; Kalani L; Jorge-Torres OC; Esteller M; Ausio J; Abian O; Velazquez-Campoy A
    Nucleic Acids Res; 2024 Apr; 52(7):3636-3653. PubMed ID: 38321951
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The iron chelator and OXPHOS inhibitor VLX600 induces mitophagy and an autophagy-dependent type of cell death in glioblastoma cells.
    Reisbeck L; Linder B; Tascher G; Bozkurt S; Weber KJ; Herold-Mende C; van Wijk SJL; Marschalek R; Schaefer L; Münch C; Kögel D
    Am J Physiol Cell Physiol; 2023 Dec; 325(6):C1451-C1469. PubMed ID: 37899749
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Spatial Immunoprofiling of Adenoid Cystic Carcinoma Reveals B7-H4 Is a Therapeutic Target for Aggressive Tumors.
    Sousa LG; McGrail DJ; Lazar Neto F; Li K; Marques-Piubelli ML; Ferri-Borgogno S; Dai H; Mitani Y; Spardy Burr N; Cooper ZA; Kinneer K; Cortez MA; Lin SY; Bell D; El Naggar A; Burks J; Ferrarotto R
    Clin Cancer Res; 2023 Aug; 29(16):3162-3171. PubMed ID: 37256648
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. First-in-Class Selective Inhibitors of the Lysine Acetyltransferase KAT8.
    Fiorentino F; Sementilli S; Menna M; Turrisi F; Tomassi S; Pellegrini FR; Iuzzolino A; D'Acunzo F; Feoli A; Wapenaar H; Taraglio S; Fraschetti C; Del Bufalo D; Sbardella G; Dekker FJ; Paiardini A; Trisciuoglio D; Mai A; Rotili D
    J Med Chem; 2023 May; 66(10):6591-6616. PubMed ID: 37155735
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [The establishment and multicenter application of internal quality control system for real-time quantitative PCR detection of BCR-ABL (P210) transcript level].
    He N; Gu CY; Li QP; Zhou H; Chu LN; Ma DX
    Zhonghua Xue Ye Xue Za Zhi; 2022 Jul; 43(7):562-567. PubMed ID: 36709133
    [No Abstract]    [Full Text] [Related]  

  • 7. Circulating mitochondrial DNA is associated with anemia in newly diagnosed hematologic malignancies.
    Yue L; Li YH; Ma RL; Niu JW; Cui HT; Sun Y; Yun ZM; Zhuo HL; Wan LM; Li SB; Zhang X; Wu CJ; Hu LD; Tan YX
    Leuk Lymphoma; 2023 Jan; 64(1):178-187. PubMed ID: 36260485
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Dual inhibition of BCL2L1 and MCL1 is highly effective against RET fusion-positive or MET exon 14 skipping mutation-positive lung adenocarcinoma cells.
    Hirai S; Idogawa M; Sumi T; Yamaguchi M; Niki T; Sakuma Y
    Biochem Biophys Res Commun; 2022 Nov; 630():24-29. PubMed ID: 36126466
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Differential Histone Posttranslational Modifications Induced by DNA Hypomethylating Agents.
    Malkaram SA; Shatnawi A; Fan J; Carraway H; Denvir J; Primerano DA; Abd Elmageed ZY; Fandy TE
    Cancer Control; 2022; 29():10732748221074051. PubMed ID: 35067084
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Drug resistance to nelarabine in leukemia cell lines might be caused by reduced expression of deoxycytidine kinase through epigenetic mechanisms.
    Yoshida K; Fujita A; Narazaki H; Asano T; Itoh Y
    Cancer Chemother Pharmacol; 2022 Jan; 89(1):83-91. PubMed ID: 34825941
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Computational modeling reveals key molecular properties and dynamic behavior of disruptor of telomeric silencing 1-like (DOT1L) and partnering complexes involved in leukemogenesis.
    Stodola TJ; Chi YI; De Assuncao TM; Leverence EN; Tripathi S; Dsouza NR; Mathison AJ; Volkman BF; Smith BC; Lomberk G; Zimmermann MT; Urrutia R
    Proteins; 2022 Jan; 90(1):282-298. PubMed ID: 34414607
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Metabolically controlled histone H4K5 acylation/acetylation ratio drives BRD4 genomic distribution.
    Gao M; Wang J; Rousseaux S; Tan M; Pan L; Peng L; Wang S; Xu W; Ren J; Liu Y; Spinck M; Barral S; Wang T; Chuffart F; Bourova-Flin E; Puthier D; Curtet S; Bargier L; Cheng Z; Neumann H; Li J; Zhao Y; Mi JQ; Khochbin S
    Cell Rep; 2021 Jul; 36(4):109460. PubMed ID: 34320364
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Cis-acting lnc-eRNA SEELA directly binds histone H4 to promote histone recognition and leukemia progression.
    Fang K; Huang W; Sun YM; Chen TQ; Zeng ZC; Yang QQ; Pan Q; Han C; Sun LY; Luo XQ; Wang WT; Chen YQ
    Genome Biol; 2020 Nov; 21(1):269. PubMed ID: 33143730
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The epigenetic treatment remodel genome-wide histone H4 hyper-acetylation patterns and affect signaling pathways in acute promyelocytic leukemia cells.
    Valiulienė G; Vitkevičienė A; Navakauskienė R
    Eur J Pharmacol; 2020 Dec; 889():173641. PubMed ID: 33045196
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Long non-coding RNA DLEUI promotes papillary thyroid carcinoma progression by sponging miR-421 and increasing ROCK1 expression.
    Li R; Wan T; Qu J; Yu Y; Zheng R
    Aging (Albany NY); 2020 Sep; 12(20):20127-20138. PubMed ID: 32910787
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Combinatorial molecule screening identified a novel diterpene and the BET inhibitor CPI-203 as differentiation inducers of primary acute myeloid leukemia cells.
    Hultmark S; Baudet A; Schmiderer L; Prabhala P; Palma-Tortosa S; Sandén C; Fioretos T; Sasidharan R; Larsson C; Lehmann S; Juliusson G; Ek F; Magnusson M
    Haematologica; 2021 Oct; 106(10):2566-2577. PubMed ID: 32855276
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. In situ exploring Chidamide, a histone deacetylase inhibitor, induces molecular changes of leukemic T-lymphocyte apoptosis using Raman spectroscopy.
    Xie Y; Tang P; Xing X; Zhao Y; Cao S; Liu S; Lu X; Zhong L
    Spectrochim Acta A Mol Biomol Spectrosc; 2020 Nov; 241():118669. PubMed ID: 32653824
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Properly Substituted Cyclic Bis-(2-bromobenzylidene) Compounds Behaved as Dual p300/CARM1 Inhibitors and Induced Apoptosis in Cancer Cells.
    Fioravanti R; Tomassi S; Di Bello E; Romanelli A; Plateroti AM; Benedetti R; Conte M; Novellino E; Altucci L; Valente S; Mai A
    Molecules; 2020 Jul; 25(14):. PubMed ID: 32650558
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Crucial Functions of the JMJD1/KDM3 Epigenetic Regulators in Cancer.
    Sui Y; Gu R; Janknecht R
    Mol Cancer Res; 2021 Jan; 19(1):3-13. PubMed ID: 32605929
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Preclinical anticancer studies on the ethyl acetate leaf extracts of Datura stramonium and Datura inoxia.
    Nasir B; Baig MW; Majid M; Ali SM; Khan MZI; Kazmi STB; Haq IU
    BMC Complement Med Ther; 2020 Jun; 20(1):188. PubMed ID: 32552791
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 14.